Mayuko Inagaki
The University of Tokyo(JP)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Atrial Fibrillation Management and Outcomes, Mast cells and histamine, Venous Thromboembolism Diagnosis and Management, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa(2013)691 cited
- → Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis(2011)116 cited
- → The Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer(2014)90 cited
- → Thienopyridines, but Not Elinogrel, Result in Off-Target Effects at the Vessel Wall That Contribute to Bleeding(2011)27 cited
- → PRT064445 but Not Recombinant Fviia Reverses Rivaroxaban Induced Anticoagulation As Measured by Reduction in Blood Loss in a Rabbit Liver Laceration Model(2012)20 cited
- → High-throughput analysis system of interaction kinetics for data-driven antibody design(2023)15 cited
- → PRT064445 reverses rivaroxaban induced anticoagulation in a rabbit liver laceration "treatment" model(2013)10 cited
- → Specific Inhibition of Syk Suppresses Leukocyte Immune Function and Alleviates Inflammation In Rodent Models of Rheumatoid Arthritis(2010)2 cited
- → Abstract 1718: Combination of Direct Acting FXa Inhibitor and P2Y 12 Antagonist at Non-Effective doses Provides Significant Inhibition of Arterial Thrombosis(2008)1 cited
- → Detection of Johne's Disease in Imported Sheep and Isolation of Sheep Strain of <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i>(2016)